4th Quarter - Report

RED MAPLE CONSULTING, LLC for RESEARCH!AMERICA

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 6, 21st Century Cures Act, all provisions, and related draft S--- Senate "Innovations" package HR 34, 21st Century Cures Act

LobbyistCovered position, as disclosed
PETE KIRKHAM —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6 (114th), H.R. 34 (114th)

Budget/Appropriations BUD

Federal funding of medical research, specifically for HR 5926 and S 3040, FY17 Labor-HHS appropriations bill (NIH, CDC, AHRQ) and HR 5054 and S 2956, FY 17 Agriculture appropriations bill (FDA) Federal funding for basic scientific research (NSF) in HR 5393 and S 2837, FY 17 Commerce, Justice-Science appropriations bill H.R.2028 Further Continuing and Security Assistance Appropriations Act

LobbyistCovered position, as disclosed
PETE KIRKHAM —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2028 (114th), H.R. 5926 (114th), H.R. 5393 (114th), H.R. 5054 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.